ABSTRACT
Healthcare-associated infections represent one of the most significant challenges for modern medicine as they can significantly impact patients’lives. Carbapenemase-producing Enterobacteriaceae (CPE) pose the greatest clinical threat, given the high levels of resistance to carbapenems, which are considered as agents of ‘last resort’ against life-threatening infections. Understanding patterns of CPE infection spreading in hospitals is paramount to design effective infection control protocols to mitigate the presence of CPE in hospitals. We used patient electronic health records from three urban hospitals to: i) track microbiologically confirmed carbapenemase producing Escherichia coli (CP-Ec) carriers and ii) trace the patients they shared place and time with until their identification. We show that yearly contact networks in each hospital consistently exhibit a core-periphery structure, highlighting the presence of a core set of wards where most carrier-contact interactions occured before being distributed to peripheral wards. We also identified functional communities of wards from the general patient movement network. The contact networks projected onto the general patient movement community structure showed a comprehensive coverage of the hospital. Our findings highlight that infections such as CP-Ec infections can reach virtually all parts of hospitals through first-level contacts.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded by the NIHR Imperial Biomedical Research Centre (NIHR-BRC-P68711). The research was conducted using National Institute of Health Research Health Informatics Collaborative data resources. Data management (and analytical support) was provided by the Big Data and Analytical Unit (BDAU) at the Institute of Global Health Innovation (IGHI). CC is supported by a personal NIHR Career Development Fellowship (grant number NIHR-2016-090-015). PE is supported by the NIHR Imperial BRC (grant number NIHR-BRC-P68711), PE and JC acknowledges support from EPSRC grant EP/N014529/1 supporting the EPSRC Centre for Mathematics of Precision Healthcare. JC acknowledges support from the Wellcome Trust (215938/Z/19/Z). EJ is a Rosetrees/Stoneygrate 2017 Imperial College Research Fellow, funded by Rosetrees Trust and the Stoneygate Trust. Imperial College London is grateful for the support from the North West London NIHR Applied Research Collaboration.The views expressed in this publication are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics for this study was granted service evaluation approval through Imperial College London NHS Trust (Ref:347). The datasets were fully anonymised and compliant with Information Commissioner's Office requirements for de-identification. Imperial College Joint Research Office is the dedicated ethics oversight body that has confirmed the study is exempt from Research Ethics Committee review.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.